NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Tapestry, Inc. (NYSE:TPR), Mallinckrodt public limited company (NYSE:MNK), Moxian, Inc. (NASDAQ:MOXC), Applied Genetic Technologies Corporation (NASDAQ:AGTC), VistaGen Therapeutics, Inc. (NASDAQ:VTGN), and Oasis Midstream Partners LP (NYSE:OMP), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
TPR DOWNLOAD: http://MarketSourceResearch.com/register/?so=TPR
MNK DOWNLOAD: http://MarketSourceResearch.com/register/?so=MNK
MOXC DOWNLOAD: http://MarketSourceResearch.com/register/?so=MOXC
AGTC DOWNLOAD: http://MarketSourceResearch.com/register/?so=AGTC
VTGN DOWNLOAD: http://MarketSourceResearch.com/register/?so=VTGN
OMP DOWNLOAD: http://MarketSourceResearch.com/register/?so=OMP
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine Tapestry, Inc. (NYSE:TPR), Mallinckrodt public limited company (NYSE:MNK), Moxian, Inc. (NASDAQ:MOXC), Applied Genetic Technologies Corporation (NASDAQ:AGTC), VistaGen Therapeutics, Inc. (NASDAQ:VTGN), and Oasis Midstream Partners LP (NYSE:OMP) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 13th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
TAPESTRY, INC. (TPR) REPORT OVERVIEW
Tapestry's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Tapestry reported revenue of $1,381.20MM vs $1,288.90MM (up 7.16%) and analysts estimated basic earnings per share $0.42 vs -$0.06. For the twelve months ended June 30th, 2018 vs June 30th, 2017, Tapestry reported revenue of $5,880.00MM vs $4,488.30MM (up 31.01%) and analysts estimated basic earnings per share $1.39 vs $2.11 (down 34.12%). Analysts expect earnings to be released on February 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.07. The estimated EPS forecast for the next fiscal year is $3.08 and is expected to report on August 13th, 2019.
To read the full Tapestry, Inc. (TPR) report, download it here: http://MarketSourceResearch.com/register/?so=TPR
-----------------------------------------
MALLINCKRODT PUBLIC LIMITED COMPANY (MNK) REPORT OVERVIEW
Mallinckrodt public limited company's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Mallinckrodt public limited company reported revenue of $640.00MM vs $600.60MM (up 6.56%) and analysts estimated basic earnings per share $1.37 vs $0.66 (up 107.58%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $2.01. The estimated EPS forecast for the next fiscal year is $7.47 and is expected to report on February 26th, 2019.
To read the full Mallinckrodt public limited company (MNK) report, download it here: http://MarketSourceResearch.com/register/?so=MNK
-----------------------------------------
MOXIAN, INC. (MOXC) REPORT OVERVIEW
Moxian's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Moxian reported revenue of $0.00MM vs $0.03MM and analysts estimated basic earnings per share -$0.03 vs -$0.03. For the twelve months ended September 30th, 2017 vs September 30th, 2016, Moxian reported revenue of $0.09MM vs $0.02MM (up 328.84%) and analysts estimated basic earnings per share -$0.21 vs -$0.17. Analysts expect earnings to be released on January 14th, 2019. The report will be for the fiscal period ending September 30th, 2018.
To read the full Moxian, Inc. (MOXC) report, download it here: http://MarketSourceResearch.com/register/?so=MOXC
-----------------------------------------
APPLIED GENETIC TECHNOLOGIES CORPORATION (AGTC) REPORT OVERVIEW
Applied Genetic Technologies' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Applied Genetic Technologies reported revenue of $14.03MM vs $10.32MM (up 36.05%) and basic earnings per share $0.07 vs -$0.08. For the twelve months ended June 30th, 2018 vs June 30th, 2017, Applied Genetic Technologies reported revenue of $24.19MM vs $39.47MM (down 38.73%) and analysts estimated basic earnings per share -$1.18 vs $0.02. Analysts expect earnings to be released on February 8th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.29. The estimated EPS forecast for the next fiscal year is -$2.03 and is expected to report on September 9th, 2019.
To read the full Applied Genetic Technologies Corporation (AGTC) report, download it here: http://MarketSourceResearch.com/register/?so=AGTC
-----------------------------------------
VISTAGEN THERAPEUTICS, INC. (VTGN) REPORT OVERVIEW
VistaGen Therapeutics' Recent Financial Performance
Analysts expect earnings to be released on February 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.24. The estimated EPS forecast for the next fiscal year is -$1.48 and is expected to report on June 25th, 2019.
To read the full VistaGen Therapeutics, Inc. (VTGN) report, download it here: http://MarketSourceResearch.com/register/?so=VTGN
-----------------------------------------
OASIS MIDSTREAM PARTNERS LP (OMP) REPORT OVERVIEW
Oasis Midstream Partners LP's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Oasis Midstream Partners LP reported revenue of $71.47MM vs $47.38MM (up 50.83%) and analysts estimated basic earnings per share $0.45 vs $0.02 (up 2,150.00%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.41. The estimated EPS forecast for the next fiscal year is $2.97 and is expected to report on February 26th, 2019.
To read the full Oasis Midstream Partners LP (OMP) report, download it here: http://MarketSourceResearch.com/register/?so=OMP
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com
© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.